Lung carcinoma tissue microarray with necrosis, single core per case. Pathology grade, TNM Classification, and Clinical Stages information available.
- 10 cases of lung adenocarcinoma with necrosis
- 10 cases of lung squamous cell carcinoma with necrosis
- 10 cases of lung small cell carcinoma with necrosis
Price
$225.00
Catalogue No | RLN702 |
Description | Lung carcinoma tissue microarray with necrosis, single core per case. Pathology grade, TNM Classification, and Clinical Stages information available. |
Species | Human |
Fixative | Formalin |
Total Cases | 30 |
Total Cores | 30 |
Core Diameter | 1.5 mm |
Section Thickness | 5 µm |
Storage | Short term RT; Long term 4ºC |
Usage | For research use only. Designed for Immunohistochemistry (IHC) and In Situ Hybridization (ISH) |
A | LU | LU | LU | LU | LU | LU | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
B | LU | LU | LU | LU | LU | LU | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
D | LU | LU | LU | LU | LU | LU | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
E | LU | LU | LU | LU | LU | LU | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
F | LU | LU | LU | LU | LU | LU | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
N | N/ | N/ | N/ | N/ | N/ | N/ | N/ | N/ | N/ | N/ | N/ | N/ | N/ | N/ | N/ | N/ | N/ | N/ | N/ | N/ | N/ | N/ | N/ | N/ | N/ | N/ | N/ | N/ | N/ | N/ | N/ | N/ | N/ | N/ | N/ | N/ | N/ | N/ | N/ | N/ | N/ | N/ | N/ | N/ | N/ | N/ | N/ | N/ | N/ | N/ | N/ | N/ | N/ | N/ | N/ | N/ | N/ | N/ | N/ | N/ | N/ | N/ | N/ | N/ | N/ | N/ | N/ | N/ | N/ | N/ | N/ | N/ | N/ | N/ | N/ | N/ | N/ | N/ | N/ | N/ | N/ | N/ |
Showing All Data
No. | Map ID | Age | Sex | Organ | Pathology Diagnosis | Grade | TNM | Stage | Type |
---|---|---|---|---|---|---|---|---|---|
1 | A1 | 59 | F | Lung | Adenocarcinoma with necrosis | 1 | T2N1M0 | II | Malignant |
2 | A2 | 51 | M | Lung | Squamous cell carcinoma with necrosis | 1 | T2N0M0 | I | Malignant |
3 | A3 | 71 | M | Lung | Small cell undifferentiated carcinoma with necrosis | - | T2N0M0 | I | Malignant |
4 | A4 | 61 | M | Lung | Adenocarcinoma with necrosis | 2 | T2N1M0 | II | Malignant |
5 | A5 | 66 | M | Lung | Squamous cell carcinoma with necrosis | 1 | T2N0M0 | I | Malignant |
6 | A6 | 62 | M | Lung | Small cell undifferentiated carcinoma with necrosis | - | T2N1M0 | II | Malignant |
7 | B1 | 59 | F | Lung | Adenocarcinoma with necrosis | 2 | T2N0M0 | I | Malignant |
8 | B2 | 63 | M | Lung | Squamous cell carcinoma with necrosis | 2 | T2N0M0 | I | Malignant |
9 | B3 | 63 | M | Lung | Small cell undifferentiated carcinoma with necrosis | - | T2N0M0 | I | Malignant |
10 | B4 | 53 | M | Lung | Adenocarcinoma with necrosis | 2 | T2N0M0 | I | Malignant |
11 | B5 | 58 | M | Lung | Squamous cell carcinoma with necrosis | 2 | T2N0M0 | I | Malignant |
12 | B6 | 36 | F | Lung | Small cell undifferentiated carcinoma with necrosis | - | T2N1M0 | II | Malignant |
13 | D1 | 69 | M | Lung | Adenocarcinoma with necrosis | 3 | T2N0M0 | I | Malignant |
14 | D2 | 70 | M | Lung | Squamous cell carcinoma with necrosis | 2 | T2N0M0 | I | Malignant |
15 | D3 | 41 | F | Lung | Small cell undifferentiated carcinoma with necrosis | - | T3N0M0 | II | Malignant |
16 | D4 | 39 | M | Lung | Adenocarcinoma with necrosis | 3 | T2N0M0 | I | Malignant |
17 | D5 | 64 | M | Lung | Squamous cell carcinoma with necrosis | 3 | T2N0M0 | I | Malignant |
18 | D6 | 58 | M | Lung | Small cell undifferentiated carcinoma with necrosis | - | T3N1M0 | IIIa | Malignant |
19 | E1 | 50 | M | Lung | Adenocarcinoma with necrosis (adenocarcinoma) | 2 | T2N0M0 | I | Malignant |
20 | E2 | 70 | M | Lung | Squamous cell carcinoma with necrosis | 2 | T2N0M0 | I | Malignant |
21 | E3 | 54 | M | Lung | Small cell undifferentiated carcinoma with necrosis | - | T3N0M0 | II | Malignant |
22 | E4 | 50 | M | Lung | Adenocarcinoma with necrosis | 3 | T1N0M0 | I | Malignant |
23 | E5 | 65 | M | Lung | Squamous cell carcinoma with necrosis | 3 | T2N1M0 | II | Malignant |
24 | E6 | 51 | M | Lung | Small cell undifferentiated carcinoma with necrosis | - | T4N1M0 | IIIb | Malignant |
25 | F1 | 65 | M | Lung | Adenocarcinoma with necrosis | 3 | T3N0M0 | II | Malignant |
26 | F2 | 55 | M | Lung | Squamous cell carcinoma with necrosis | 2 | T2N1M0 | II | Malignant |
27 | F3 | 28 | M | Lung | Small cell undifferentiated carcinoma with necrosis | - | T2N1M0 | II | Malignant |
28 | F4 | 59 | M | Lung | Adenocarcinoma with necrosis | 3 | T2N0M0 | I | Malignant |
29 | F5 | 68 | M | Lung | Squamous cell carcinoma with necrosis | 3 | T4N1M0 | IIIb | Malignant |
30 | F6 | 44 | M | Lung | Small cell undifferentiated carcinoma with necrosis (small cell undifferentiated carcinoma) | - | T4N2M0 | IIIb | Malignant |
N/A | N/A | N/A | N/A | N/A | _pheochromocytoma_ Tissue Marker | N/A | N/A | N/A | N/A |
N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |